Angiogenesis 2024: AVD-104 for Geographic Atrophy

Carl Danzig, MD, sat down with Martin David Harp of Ophthalmology Times to discuss his presentation AVD-104 for Geographic Atrophy: Glyco-immunologic modulation of macrophage activity from the Angiogenesis Exudation and Degeneration 2024 event.

Related Videos

Related Content

Advertisement

May 19th 2025

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

May 17th 2025

Q&A: Joaquin De Rojas, MD, on ASCRS 2025 Best Paper of Session for advancing AK with machine learning

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

May 16th 2025

AAVantgarde Bio presents positive data for retinitis pigmentosa and Stargardt disease therapies

May 16th 2025

Q&A: Anat Loewenstein, MD, and results of a consensus group on managing diabetic retinopathy

Related Content

Advertisement

May 19th 2025

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases

December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

May 17th 2025

Q&A: Joaquin De Rojas, MD, on ASCRS 2025 Best Paper of Session for advancing AK with machine learning

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

May 16th 2025

AAVantgarde Bio presents positive data for retinitis pigmentosa and Stargardt disease therapies

May 16th 2025

Q&A: Anat Loewenstein, MD, and results of a consensus group on managing diabetic retinopathy